United Therapeutics (UTHR) Gross Margin Growth (3y) (2012 - 2026)
United Therapeutics (UTHR) Gross Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 567.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -100.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -196.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -228.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 12.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -61.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.07 Bn | 7.41 Bn | 397.90 Mn | -954.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -196.00 |
| Mar 31, 2026 | -675.00 |
| Dec 31, 2025 | -112.00 |
| Sep 30, 2025 | -541.00 |
| Jun 30, 2025 | -461.00 |
| Mar 31, 2025 | -604.00 |
| Dec 31, 2024 | -198.00 |
| Sep 30, 2024 | -487.00 |
| Jun 30, 2024 | -255.00 |
| Mar 31, 2024 | -469.00 |
| Dec 31, 2023 | -251.00 |
| Sep 30, 2023 | -519.00 |
| Jun 30, 2023 | -359.00 |
| Mar 31, 2023 | -375.00 |
| Dec 31, 2022 | -271.00 |
| Sep 30, 2022 | 101.00 |
| Jun 30, 2022 | 79.00 |
| Mar 31, 2022 | 242.00 |
| Dec 31, 2021 | 3.00 |
| Sep 30, 2021 | 635.00 |